TLSA (Tiziana Life Sciences) Moat Score: 2/10 (As of Jun. 26, 2026)


TLSA Tiziana Life Sciences Ltd TLSA
26 GF Score
Price $1.20
! 2 Warning Signs
View Full Analysis

What is Tiziana Life Sciences Moat Score?

Tiziana Life Sciences TLSA +4.42% 26 Moat Score is 2 as of Jun. 26, 2026. GuruFocus rates TLSA with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 1,404 Biotechnology companies, Tiziana Life Sciences ranks better than 58.12% on this metric.

Tiziana Life Sciences has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Tiziana Life Sciences has No Moat: Tiziana Life Sciences operates in the biotech sector with high R&D costs and uncertain outcomes. It lacks significant patents, brand strength, or market leadership. The company faces intense competition and does not have a durable cost advantage or significant regulatory barriers.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Tiziana Life Sciences might have No Moat - Very weak/transient advantages.

Tiziana Life Sciences  (NAS:TLSA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Tiziana Life Sciences Moat Score Related Terms

TLSA vs DTIL, MIST, EQ: Moat Score Comparison

For the Biotechnology subindustry, Tiziana Life Sciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tiziana Life Sciences Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tiziana Life Sciences's Moat Score distribution charts can be found below:

* The bar in red indicates where Tiziana Life Sciences's Moat Score falls into.


TLSA
26GF Score
Tiziana Life Sciences Ltd TLSA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Tiziana Life Sciences (TLSA) has a Moat Score of 2 as of Jun. 26, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Tiziana Life Sciences ranks #588 out of 1404 companies in the Biotechnology industry, placing it in the top 41.9%.
Is Tiziana Life Sciences' Moat Score too high?
Tiziana Life Sciences' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Tiziana Life Sciences' value of 2 is 0% at this industry median. Based on the distribution chart, Tiziana Life Sciences ranks #588 out of 1404 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Tiziana Life Sciences has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Tiziana Life Sciences' Moat Score compare to DTIL and MIST?
According to the Biotechnology industry distribution chart, Tiziana Life Sciences ranks #588 out of 1404 companies for Moat Score. This puts Tiziana Life Sciences in the upper half of its industry. The industry median Moat Score is 2.00. Tiziana Life Sciences' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,404 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tiziana Life Sciences's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tiziana Life Sciences's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tiziana Life Sciences stock overvalued right now?
Tiziana Life Sciences (TLSA) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Tiziana Life Sciences' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Tiziana Life Sciences (TLSA), the current Moat Score is 2 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tiziana Life Sciences Business Description

Other Exchanges 0RP:Germany
Address 2 Church Street, Clarendon House, Hamilton, BMU, HM 11
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
26GF Score

Get the complete analysis for TLSA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.20
Price